Long-Lasting Response to Trabectedin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report

BACKGROUND: Uterine leiomyosarcoma (uLMS) is a rare tumor that accounts for 1% of all uterine malignancies. In spite of adequate surgical resection of uLMS, even in the early stage, patients remain at high risk for local and distant recurrence. Therefore, the treatment of advanced uLMS represents a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nteli, Viktoria-Anna, Knauf, Wolfgang, Janton-Klein, Anja, El-Safadi, Samer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836215/
https://www.ncbi.nlm.nih.gov/pubmed/29515415
http://dx.doi.org/10.1159/000486638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836215/
https://www.ncbi.nlm.nih.gov/pubmed/29515415
http://dx.doi.org/10.1159/000486638

Ejemplares similares